It is also worth noting that the CCL6 ortholog gene product in human, CCL23, has been reported as a diagnostic biomarker in the serum or cerebrospinal fluid of patients with Alzheimer’s disease and ischemic stroke72,73. This evidence concerns the gene CCL23 and Alzheimer disease.